About this podcast:
Recorded at the 2025 DPHARM conference, this state of the union panel convenes site, technology and pharma perspectives to discuss: different models and the pros and cons of the deployment models; what makes a great patient matching solution; predicting what the future growth of this segment looks like; and the role of AI.
Moderators
Chelsea Osterman, MD
Senior Medical Director
Tempus
Alyssa Tarantino,
Innovation Lead
BMS
Adrienne Walstrum, MSc
Senior Director, Global Trial Optimization
Merck
Michaela Bertram,
Clinical Cancer Research Manager
Avera Cancer Institute
Benjamin Jackson,
VP Commercial
SanoGenetics
Speakers
Sean Lynch,
Innovative Capabilities Head, Innovative Trial Operations
Novartis
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.